Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Abgrall, S; Charreau, I; Joly, V; Bloch, J; Reynes, J; Yeni, P
   Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues
   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
   
   S. Abgrall et al., "Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues", EUR J CL M, 20(5), 2001, pp. 346-349
2. Auzary, C; Pinganaud, C; Launay, O; Joly, V; Cremieux, AC; Idatte, JM; Carbon, C
   Prosthetic valve endocarditis due to Coxiella burnetii: six cases.
   REVUE DE MEDECINE INTERNE
   
   C. Auzary et al., "Prosthetic valve endocarditis due to Coxiella burnetii: six cases.", REV MED IN, 22(10), 2001, pp. 948-958
3. Hance, AJ; Lemiale, V; Izopet, J; Lecossier, D; Joly, V; Massip, P; Mammano, F; Descamps, D; Brun-Vezinet, F; Clavel, F
   Changes in human immunodeficiency virus type 1 populations after treatmentinterruption in patients failing antiretroviral therapy
   JOURNAL OF VIROLOGY
   
   A.J. Hance et al., "Changes in human immunodeficiency virus type 1 populations after treatmentinterruption in patients failing antiretroviral therapy", J VIROLOGY, 75(14), 2001, pp. 6410-6417
4. Chanetz, B; Pot, T; Bur, R; Joly, V; Larigaldie, S; Lefebvre, M; Marmignon, C; Mohamed, AK; Perraud, J; Pigache, D; Sagnier, P; Verant, JL; William, J
   High-enthalpy hypersonic project at ONERA
   AEROSPACE SCIENCE AND TECHNOLOGY
   
   B. Chanetz et al., "High-enthalpy hypersonic project at ONERA", AEROSP SC T, 4(5), 2000, pp. 347-361
5. Chemlal, K; Nochy, D; Kenouch, S; Joly, V; Carbon, C
   Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy
   CLINICAL INFECTIOUS DISEASES
   
   K. Chemlal et al., "Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy", CLIN INF D, 31(3), 2000, pp. 805-806
6. Joly, V; Moroni, M; Concia, E; Lazzarin, A; Hirschel, B; Jost, J; Chiodo, F; Bentwich, Z; Love, WC; Hawkins, DA; Wilkins, EGL; Gatell, AJ; Vetter, N; Greenwald, C; Freimuth, WW; De Cian, W
   Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial
   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
   
   V. Joly et al., "Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial", ANTIM AG CH, 44(11), 2000, pp. 3155-3157
7. Joly, V; Yeni, P
   Non-nucleosidic reverse transcriptase inhibitors
   ANNALES DE MEDECINE INTERNE
   
   V. Joly e P. Yeni, "Non-nucleosidic reverse transcriptase inhibitors", ANN MED IN, 151(4), 2000, pp. 260-267
8. Grisch, F; Bouchardy, P; Joly, V; Marmignon, C; Koch, U; Gulhan, A
   Coherent anti-Stokes Raman scattering measurements and computational modeling of nonequilibrium flow
   AIAA JOURNAL
   
   F. Grisch et al., "Coherent anti-Stokes Raman scattering measurements and computational modeling of nonequilibrium flow", AIAA J, 38(9), 2000, pp. 1669-1675
9. Joly, V; Marmignon, C; Jacquet, P
   Vibrational relaxation of CO2(m, n(l), p) in a CO2-N-2 mixture. Part 2: Application to a one-dimensional problem
   AEROSPACE SCIENCE AND TECHNOLOGY
   
   V. Joly et al., "Vibrational relaxation of CO2(m, n(l), p) in a CO2-N-2 mixture. Part 2: Application to a one-dimensional problem", AEROSP SC T, 3(5), 1999, pp. 313-322
10. Joly, V; Roblin, A
    Vibrational relaxation of CO2 (m, n(l), p) in a CO2-N-2 mixture. Part 1: Survey of available data
    AEROSPACE SCIENCE AND TECHNOLOGY
    
    V. Joly e A. Roblin, "Vibrational relaxation of CO2 (m, n(l), p) in a CO2-N-2 mixture. Part 1: Survey of available data", AEROSP SC T, 3(4), 1999, pp. 229-238
11. Reynes, J; Raffi, F; Joly, V; Nevez, G; Dupont, B
    Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study I. Clinical assessment
    JOURNAL DE MYCOLOGIE MEDICALE
    
    J. Reynes et al., "Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study I. Clinical assessment", J MYCOL MED, 9(2), 1999, pp. 83-87
12. Been-Tiktak, AMM; Boucher, CAB; Brun-Vezinet, F; Joly, V; Mulder, JW; Jost, J; Cooper, DA; Moroni, M; Gatell, JM; Staszewski, S; Colebunders, R; Stewart, GJ; Hawkins, DA; Johnson, MA; Parkin, JM; Kennedy, DH; Hoy, JF; Borleffs, JCC
    Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    A.M.M. Been-Tiktak et al., "Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial", INT J ANT A, 11(1), 1999, pp. 13-21
13. JOLY V; CARBON C
    EDITORIAL RESPONSE - UNFORTUNATE IN-VITRO SELECTION OF RESISTANT CANDIDA-ALBICANS WITH SEVERE CLINICAL CONSEQUENCES
    Clinical infectious diseases
    
    V. Joly e C. Carbon, "EDITORIAL RESPONSE - UNFORTUNATE IN-VITRO SELECTION OF RESISTANT CANDIDA-ALBICANS WITH SEVERE CLINICAL CONSEQUENCES", Clinical infectious diseases, 27(4), 1998, pp. 692-694
14. DARRASJOLY C; LUCET JC; LAISSY JP; CHOCHILLON C; CASALINO E; JOLY V; MATHERON S; BOUVET E
    INVASIVE ASPERGILLOSIS IN AIDS
    Pathologie et biologie
    
    C. Darrasjoly et al., "INVASIVE ASPERGILLOSIS IN AIDS", Pathologie et biologie, 46(6), 1998, pp. 416-417
15. Besson, C; Stelianides, S; Belmatoug, N; Silbermann-Hoffman, O; Couvelard, A; Joly, V; Carbon, C; Fantin, B
    Multifocal osteonecrosis after chemotherapy in a patient with breast cancer
    JOURNAL OF RHEUMATOLOGY
    
    C. Besson et al., "Multifocal osteonecrosis after chemotherapy in a patient with breast cancer", J RHEUMATOL, 25(12), 1998, pp. 2479-2480
16. Petit, C; Cheron, M; Joly, V; Rodrigues, JM; Bolard, J; Gaboriau, F
    In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating
    Journal of antimicrobial chemotherapy
    
    C. Petit et al., "In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating", J ANTIMICRO, 42(6), 1998, pp. 779-785
17. Broc, A; Joly, V; Lafon, JPJ; Marmignon, C
    Nonequilibrium radiative hypersonic flows: Aerospace applications
    ASTROPHYSICS AND SPACE SCIENCE
    
    A. Broc et al., "Nonequilibrium radiative hypersonic flows: Aerospace applications", ASTRO SP SC, 260(1-2), 1998, pp. 29-43
18. JOLY V; BELMATOUG N; LEPERRE A; ROBERT J; JAULT F; CARBON C; YENI P
    PACEMAKER ENDOCARDITIS DUE TO CANDIDA-ALBICANS - CASE-REPORT AND REVIEW
    Clinical infectious diseases
    
    V. Joly et al., "PACEMAKER ENDOCARDITIS DUE TO CANDIDA-ALBICANS - CASE-REPORT AND REVIEW", Clinical infectious diseases, 25(6), 1997, pp. 1359-1362
19. ABGRALL S; JOLY V; DERKINDEREN P; DECRE D; CARBON C; YENI P
    LACTOBACILLUS-CASEI INFECTION IN AN AIDS PATIENT
    European journal of clinical microbiology & infectious diseases
    
    S. Abgrall et al., "LACTOBACILLUS-CASEI INFECTION IN AN AIDS PATIENT", European journal of clinical microbiology & infectious diseases, 16(2), 1997, pp. 180-182
20. JOLY V; MARMIGNON C
    EFFECT OF H2O VAPOR ON THE VIBRATIONAL-RELAXATION IN HYPERSONIC WIND TUNNELS
    Journal of thermophysics and heat transfer
    
    V. Joly e C. Marmignon, "EFFECT OF H2O VAPOR ON THE VIBRATIONAL-RELAXATION IN HYPERSONIC WIND TUNNELS", Journal of thermophysics and heat transfer, 11(2), 1997, pp. 266-272
21. SEUXLEVIEIL ML; JOLY V; YENI P; CARBON C; BLANCHET F
    EVALUATION OF RENAL ACIDIFICATION IN HIV-INFECTED PATIENTS WITH HYPERGAMMAGLOBULINEMIA
    Nephron
    
    M.L. Seuxlevieil et al., "EVALUATION OF RENAL ACIDIFICATION IN HIV-INFECTED PATIENTS WITH HYPERGAMMAGLOBULINEMIA", Nephron, 75(2), 1997, pp. 196-200
22. JOLY V
    INFECTION PROPHYLAXIS IN IMMUNOSUPPRESSED PATIENTS - PREVENTION OF TRANSFUSION-TRANSMITTED INFECTIONS
    Annales de medecine interne
    
    V. Joly, "INFECTION PROPHYLAXIS IN IMMUNOSUPPRESSED PATIENTS - PREVENTION OF TRANSFUSION-TRANSMITTED INFECTIONS", Annales de medecine interne, 148(3), 1997, pp. 268-271
23. JOLY V; AUBRY P; NDAYIRAGIDE A; CARRIERE I; KAWA E; MLIKACABANNE N; ABOULKER JP; COULAUD JP; LAROUZE B; YENI P
    RANDOMIZED COMPARISON OF AMPHOTERICIN-B DEOXYCHOLATE DISSOLVED IN DEXTROSE OR INTRALIPID FOR THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS
    Clinical infectious diseases
    
    V. Joly et al., "RANDOMIZED COMPARISON OF AMPHOTERICIN-B DEOXYCHOLATE DISSOLVED IN DEXTROSE OR INTRALIPID FOR THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS", Clinical infectious diseases, 23(3), 1996, pp. 556-562
24. DARRASJOLY C; CHEVRET S; WOLFF M; MATHERON S; LONGUET P; CASALINO E; JOLY V; CHOCHILLON C; BEDOS JP
    CRYPTOCOCCUS-NEOFORMANS INFECTION IN FRANCE - EPIDEMIOLOGIC FEATURES OF AND EARLY PROGNOSTIC PARAMETERS FOR 76 PATIENTS WHO WERE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    Clinical infectious diseases
    
    C. Darrasjoly et al., "CRYPTOCOCCUS-NEOFORMANS INFECTION IN FRANCE - EPIDEMIOLOGIC FEATURES OF AND EARLY PROGNOSTIC PARAMETERS FOR 76 PATIENTS WHO WERE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS", Clinical infectious diseases, 23(2), 1996, pp. 369-376
25. JOLY V; BELMATOUG N; SIBERT A; CARBON C; YENI P
    SEPTIC THROMBOPHLEBITIS OF THE PORTAL-VEIN
    Clinical infectious diseases
    
    V. Joly et al., "SEPTIC THROMBOPHLEBITIS OF THE PORTAL-VEIN", Clinical infectious diseases, 23(2), 1996, pp. 417-418
26. FANTIN B; JOLY V; ELBIM C; GOLMARD JL; GOUGEROTPOCIDALO MA; YENI P; CARBON C
    LYMPHOCYTE SUBSET COUNTS DURING THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA - EVOLUTION ACCORDING TO AGE, HUMAN-IMMUNODEFICIENCY-VIRUS STATUS, AND ETIOLOGIC MICROORGANISMS
    Clinical infectious diseases
    
    B. Fantin et al., "LYMPHOCYTE SUBSET COUNTS DURING THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA - EVOLUTION ACCORDING TO AGE, HUMAN-IMMUNODEFICIENCY-VIRUS STATUS, AND ETIOLOGIC MICROORGANISMS", Clinical infectious diseases, 22(6), 1996, pp. 1096-1098
27. JOLY V; GEOFFRAY C; REYNES J; GOUJARD C; MECHALI D; MASLO C; RAFFI F; YENI P
    AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS
    Journal of antimicrobial chemotherapy
    
    V. Joly et al., "AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS", Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 117-126
28. CHEMLAL K; SAINTJULIEN L; JOLY V; FARINOTTI R; SETA N; YENI P; CARBON C
    COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS
    Antimicrobial agents and chemotherapy
    
    K. Chemlal et al., "COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS", Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 263-266
29. JOLY V; KALFON P; POETE P; BODIN L; PUYBASSET L; CORIAT P; ROUBY JJ
    USE OF THE SAME HEAT AND MOISTURE EXCHANGER FOR 48 H IN INTENSIVE-CARE UNIT VENTILATED PATIENTS
    British Journal of Anaesthesia
    
    V. Joly et al., "USE OF THE SAME HEAT AND MOISTURE EXCHANGER FOR 48 H IN INTENSIVE-CARE UNIT VENTILATED PATIENTS", British Journal of Anaesthesia, 76, 1996, pp. 345-345
30. BEENTIKTAK AMM; JOLY V; SITBON G; COLLIN G; DEVOS M; DEGRAAF L; DEHAAN C; BOUCHER C; BRUMVEZINET F
    COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    A.M.M. Beentiktak et al., "COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL", Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 48-48
31. JOLY V; YENI P
    NUCLEOTIDE ANALOGS FOR TREATMENT OF HIV-I NFECTION - NEW DATA
    La Presse medicale
    
    V. Joly e P. Yeni, "NUCLEOTIDE ANALOGS FOR TREATMENT OF HIV-I NFECTION - NEW DATA", La Presse medicale, 24(2), 1995, pp. 103
32. JOLY V
    VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS
    Medecine et maladies infectieuses
    
    V. Joly, "VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS", Medecine et maladies infectieuses, 25(BIS), 1995, pp. 27-31
33. JOLY V
    VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS
    Medecine et maladies infectieuses
    
    V. Joly, "VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS", Medecine et maladies infectieuses, 25, 1995, pp. 27-31
34. JOLY V
    BRITTANY DURING THE WAR, 1939-1945 - FREN CH - SAINCLIVIER,J
    Annales de Bretagne et des pays de l'Ouest
    
    V. Joly, "BRITTANY DURING THE WAR, 1939-1945 - FREN CH - SAINCLIVIER,J", Annales de Bretagne et des pays de l'Ouest, 101(4), 1994, pp. 120-121
35. JOLY V
    PREVENTION OF INVASIVE ASPERGILLOSIS VALU E OF CHEMOPROPHYLAXIS
    Pathologie et biologie
    
    V. Joly, "PREVENTION OF INVASIVE ASPERGILLOSIS VALU E OF CHEMOPROPHYLAXIS", Pathologie et biologie, 42(7), 1994, pp. 694-699
36. CHAVANET P; JOLY V; RIGAUD D; BOLARD J; CARBON C; YENI P
    INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE
    Antimicrobial agents and chemotherapy
    
    P. Chavanet et al., "INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE", Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 963-968
37. JOLY V; FARINOTTI R; SAINTJULIEN L; CHERON M; CARBON C; YENI P
    IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID
    Antimicrobial agents and chemotherapy
    
    V. Joly et al., "IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID", Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 177-183
38. JOLY V; COQUEL F; MARMIGNON C; ARETZ W; METZ S; WILHELMI H
    NUMERICAL MODELING OF HEAT-TRANSFER AND RELAXATION IN NONEQUILIBRIUM AIR AT HYPERSONIC SPEEDS
    La Recherche aerospatiale
    
    V. Joly et al., "NUMERICAL MODELING OF HEAT-TRANSFER AND RELAXATION IN NONEQUILIBRIUM AIR AT HYPERSONIC SPEEDS", La Recherche aerospatiale, (3), 1994, pp. 219-234
39. JOLY V; SAINTJULIEN L; CARBON C; YENI P
    IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS
    The Journal of infectious diseases
    
    V. Joly et al., "IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS", The Journal of infectious diseases, 170(5), 1994, pp. 1331-1334
40. SABA J; MORLAT P; RAFFI F; HAZEBROUCQ V; JOLY V; LEPORT C; VILDE JL
    PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS
    European journal of clinical microbiology & infectious diseases
    
    J. Saba et al., "PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS", European journal of clinical microbiology & infectious diseases, 12(11), 1993, pp. 853-856